E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/2/2006 in the Prospect News Biotech Daily.

Abiomed files shelf for 7.5 million common shares

By Laura Lutz

Des Moines, Oct. 2 - Abiomed, Inc. registered 7.5 million shares of common stock in an S-3 filing with the Securities and Exchange Commission.

The company plans to use the proceeds for building its global distribution, research and development and for general corporate purposes.

Abiomed is a provider of medical products and services focusing on circulatory care.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.